Publicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (14)

2023

  1. The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)

    International journal of molecular sciences, Vol. 24, Núm. 13

2018

  1. Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study

    Human Pathology, Vol. 72, pp. 100-106

2017

  1. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer

    Journal of Pathology, Vol. 241, Núm. 4, pp. 475-487

  2. Undifferentiated and Dedifferentiated Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis

    American Journal of Surgical Pathology, Vol. 41, Núm. 8, pp. 1121-1128

2016

  1. Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer

    Oncotarget, Vol. 7, Núm. 35, pp. 56295-56308

  2. Mixed and ambiguous endometrial carcinomas

    American Journal of Surgical Pathology, Vol. 40, Núm. 7, pp. 972-981

  3. Molecular genetic heterogeneity in undifferentiated endometrial carcinomas

    Modern Pathology, Vol. 29, Núm. 11, pp. 1390-1398

2015

  1. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873

2013

  1. Endometrial carcinoma: Molecular alterations involved in tumor development and progression

    Oncogene, Vol. 32, Núm. 4, pp. 403-413

2012

  1. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers

    BMC Medical Genomics, Vol. 5

  2. Prospective transGEICAM study of the impact of the 21-gene recurrence score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer

    Annals of Oncology, Vol. 23, Núm. 3, pp. 625-631

  3. The EMT signaling pathways in endometrial carcinoma

    Clinical and Translational Oncology, Vol. 14, Núm. 10, pp. 715-720

2009

  1. Transitional cell tumors of the ovary: A comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of brenner tumors and transitional cell carcinomas

    American Journal of Surgical Pathology, Vol. 33, Núm. 4, pp. 556-567

2001

  1. Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors

    Cancer, Vol. 92, Núm. 11, pp. 2829-2836